Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. - Wikidata - wikimedia - TriplyDB

Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta.

Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta.

http://www.wikidata.org/entity/Q45967050

about

Splice isoform estrogen receptors as integral transmembrane proteins Minireview: Recent advances in extranuclear steroid receptor actions Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiency Localization and divergent profiles of estrogen receptors and aromatase in the vocal and auditory networks of a fish with alternative mating tactics.Membrane initiated estrogen signaling in breast cancer.Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions.p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGF.Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats.ERβ selective agonist inhibits angiotensin-induced cardiovascular pathology in female mice Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.Endothelial estrogen receptor isoforms and cardiovascular disease Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure.Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease Development of subtype-selective oestrogen receptor-based therapeutics.Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential.Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.Minireview: Extranuclear steroid receptors: roles in modulation of cell functions.Estrogen signaling in the cardiovascular system.Non-nuclear estrogen receptor signaling in the endothelium.Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat.Relaxin induces rapid dilation of rodent small renal and human subcutaneous arteries via PI3 kinase and nitric oxide.Increased atherosclerosis in mice with vascular ATP-binding cassette transporter G1 deficiency--brief report.The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.Vascular effects of estrogenic menopausal hormone therapy.Pro-survival effects of 17β-estradiol on osteocytes are mediated by nitric oxide/cGMP via differential actions of cGMP-dependent protein kinases I and II Nontranscriptional activation of PI3K/Akt signaling mediates hypotensive effect following activation of estrogen receptor β in the rostral ventrolateral medulla of rats.Rapid control of male typical behaviors by brain-derived estrogens Point mutations in the ERα Gαi binding domain segregate nonnuclear from nuclear receptor function The role of sex in cardiac function and disease.Plasma membrane estrogen receptors.Life history of eNOS: partners and pathways.Rapid signaling by steroid receptors.The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System.Membrane-initiated actions of estrogen on the endothelium.Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats Increased Expression of Pyloric ERβ Is Associated With Diabetic Gastroparesis in Streptozotocin-Induced Male Diabetic Rats.Increased NO bioavailability in aging male rats by genistein and exercise training: using 4, 5-diaminofluorescein diacetate.

P2860

Q24338464-27827F14-B335-4C1B-A44B-346D92E82544 Q27022118-AC9C1515-91A8-4CCD-AF18-960F1F9B49D9 Q27349876-A14D941D-0380-4D80-ACB2-53A80B984F50 Q30432917-ED1921B0-16D4-4303-B326-6E17CF69AEF5 Q30439994-C1DC7017-7760-4DA6-A3BA-600B3C62EF94 Q30565938-EE19A8FC-3092-4E86-9701-A04D864C8FA3 Q31108919-5FC683C7-6D1F-421F-8628-4970D50F085A Q33579228-11960D8F-EB84-4F3E-ACD9-2DD92B882350 Q33584903-B327359D-3545-4C94-A759-A7CC530C156F Q33631509-C28BB166-7536-471D-8B0E-9031001515CF Q33693303-F19AFB1C-C5FC-4389-9677-0A1F31CC99F5 Q33781367-DCD1FF4E-4D12-48C1-A0F3-A21B08725A32 Q33786755-B54E1D1B-635E-4C47-AEEC-AE587178E92F Q33815579-810F2CAE-BCB6-46F4-B7CF-922CA3EABE75 Q33835934-DA8BCC6F-ABDF-4097-9DB3-9D09F24EE100 Q34043346-55792B30-3FEE-4B6D-8737-D4900AA7A8DC Q34216817-B61BD6D2-A8DD-4227-8AFF-9703580E4DF0 Q34315419-46116197-3F22-4D63-B7E4-AF4E6BE4079C Q34375771-B48351E6-844B-4426-978A-FB19A6070985 Q34609967-0099CB9A-F16D-4DF7-9A79-5245217AF4DC Q34803352-755F8FAB-5CB9-4AD7-80AD-922DAC227105 Q34868756-A67A17D9-C2A6-4E7C-8A1D-413A52E72941 Q34984856-986BF28B-C48F-45C8-918C-49CB0A243A11 Q35046881-CDCC06A8-F854-46BB-A4A5-C88CDEDC147F Q35050020-8134C7FC-21B6-4169-BE50-EFFF24B763A5 Q35551803-768299F7-8BB6-4154-AA03-ACEC5F569668 Q35583311-37275163-60C1-4C7D-A4BD-4CD451E31279 Q35668850-0B8FC064-1867-484A-9644-CDF5D740EF5D Q36222580-FB9C9B8C-4A10-425E-9BF4-C39D4A4DC041 Q36392745-25F3A13B-BEE9-4D6E-99BB-4DB34B953400 Q36533410-BE39E9D0-8016-4801-8F3D-68B720A99449 Q36538376-F665BBB8-B5A6-4BEF-A74A-675502A75B87 Q36660250-1648F5DA-EDEA-4852-85A3-71A049FB30DC Q36805328-103151D3-AE97-4194-AE2C-FF6C5BF20552 Q36977236-89200EC8-9D4C-4235-AC2E-1B5C8C7301F2 Q37234859-208C7BB8-EB5C-4662-A367-DCB704B57BEE Q37241510-96B80914-1CA1-4EC9-A045-5D9C63593C84 Q37281328-CF57A893-B396-4947-9E76-727EFDDC4908 Q37292915-E206ADE7-4B5E-4399-A66A-A1A7D1B6919B Q37356167-55BB1D31-2537-409B-B67E-8E78DA7CFB77

P2860

Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta.

http://www.wikidata.org/entity/Q45967050

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Estrogen induces vascular wall ...... ogen receptors alpha and beta.

@en

Estrogen induces vascular wall ...... ogen receptors alpha and beta.

@nl

type

label

Estrogen induces vascular wall ...... ogen receptors alpha and beta.

@en

Estrogen induces vascular wall ...... ogen receptors alpha and beta.

@nl

prefLabel

Estrogen induces vascular wall ...... ogen receptors alpha and beta.

@en

Estrogen induces vascular wall ...... ogen receptors alpha and beta.

@nl

P1433

Q45967050-77DB5084-D0A7-406B-978A-38D376126CCD

P1476

Q45967050-A6E8883C-D66C-4C1E-A032-B5C1C7392440

P2093

Q45967050-0BE62859-B72A-4DB1-9FCD-FEA38CF7F2A0

Q45967050-16D08B59-3C2C-4DBB-B69E-52417D0C59B0

Q45967050-27B88CC9-2DDE-4DD4-ABF0-6D90CD7FE341

Q45967050-3D6758E0-5BFB-48B8-B012-DCEC6B8837FA

Q45967050-A7F53388-C085-4D14-B39A-42318F6B0E4E

P2860

Q45967050-170EB059-0ACC-4410-811A-8F2756878CB7

Q45967050-205AA3A2-438D-4F13-854B-83FADFC939D2

Q45967050-375CB843-36C8-452E-A080-DC58089D4F91

Q45967050-4F481D4A-C0AA-489B-A0CE-E7B0D87FA380

Q45967050-5277CF47-B4FD-4634-9C21-4F796BF925CC

Q45967050-546C7A83-DFC0-4B22-8F0E-FCAAEB5EA505

Q45967050-5671D657-88D8-48CF-A620-9510D58BF825

Q45967050-573EC971-FCB8-4448-B97F-51F97CC34F35

Q45967050-64C249A5-2890-4DC8-86E1-DC83122728D6

Q45967050-78A3E341-E012-4EC5-A4B4-FFEB9DB47008

P304

Q45967050-FEAF7603-EA6F-44E9-86FC-249E78CE3DB7

P31

Q45967050-A6D52AF5-A00A-4E78-BF97-20EBAFD70F6B

P356

Q45967050-23CEFB2E-E665-45AC-9DC2-1B084CD22ABF

P407

Q45967050-63C95E09-7CFF-496B-B317-3A21549611DB

P433

Q45967050-51CB1E1D-A76D-4DD9-92B3-39757E69ABCE

P478

Q45967050-9DB97341-E416-4E89-9CC9-6D0CFD76253D

P577

Q45967050-66F32735-E478-4472-940B-E41491BA87D9

P698

Q45967050-F95ECE7F-964D-4D79-B868-D4D4B9FD6C57

P356

P1433

Journal of Biological Chemistry

P1476

Estrogen induces vascular wall ...... ogen receptors alpha and beta.

@en

P2093

Ali Pedram

http://www.w3.org/2001/XMLSchema#string

Ellis R Levin

http://www.w3.org/2001/XMLSchema#string

Ghassan Kassab

http://www.w3.org/2001/XMLSchema#string

Mahnaz Razandi

http://www.w3.org/2001/XMLSchema#string

Xiaomei Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase

Estradiol signaling via sequestrable surface receptors.

Variations in endothelial function and arterial compliance during the menstrual cycle.

Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen.

17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease.

Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women.

Estrogen modulation of endothelial nitric oxide synthase.

Induction of calcium-dependent nitric oxide synthases by sex hormones.

Coronary vasospasm and the regulation of coronary blood flow.

P304

19704-19710

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M501244200

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15764600

http://www.w3.org/2001/XMLSchema#string